Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Size, Value And Growth Trajectory Through 2030
The messenger ribonucleic acid (mrna) synthesis raw materials market size has experienced consistent expansion in recent years. Its growth is anticipated to be from $3.03 billion in 2025 to $3.12 billion in 2026, reflecting a compound annual growth rate (CAGR) of 3.0%. This historical growth can be ascribed to a growing demand for vaccines, advancements in molecular biology, increasing r&d investments in synthetic biology, the rise of infectious disease outbreaks, and the development of efficient transcription enzymes.
The market size for messenger ribonucleic acid (mRNA) synthesis raw materials is anticipated to experience consistent growth over the next few years. It will grow to $3.65 billion in 2030 at a compound annual growth rate (CAGR) of 4.0%. This projected growth is primarily fueled by the increasing prevalence of mRNA-based therapeutics, the uptake of automated mRNA synthesis platforms, a surge in personalized medicine initiatives, the expansion of biotechnology manufacturing hubs, and breakthroughs in nucleotide modifications. Significant trends expected during the forecast period include the optimization of synthetic mRNA, the advancement of high-purity raw material development, the implementation of scalable in-vitro transcription processes, the standardization of the supply chain for mRNA production, and stringent quality control coupled with regulatory compliance.
Get A Free Sample Report With In-Depth Market Insights:
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Development Factors: What’s Supporting Demand?
The increasing occurrence of cancer and persistent health conditions is anticipated to fuel the expansion of the mRNA synthesis raw materials market in the future. Cancer is characterized as a condition where abnormal cells multiply without regulation, capable of invading adjacent tissues and potentially spreading to distant parts of the body through the bloodstream and lymphatic systems. Chronic illnesses are generally defined as health issues that last for at least a year, require ongoing medical care, hinder daily activities, or a combination of these factors. These raw materials for mRNA synthesis find application in drug discovery, vaccine creation, and the production of RNA-based therapeutics, providing enhanced immunogenicity, greater efficacy, and quicker production, suitable for addressing cancer and chronic ailments. For example, data released by the American Cancer Society, a US-based non-profit organization, in January 2024, forecasts that the United States will experience 2,001,140 new cancer cases and 611,720 cancer deaths in 2024, an increase from 1,958,310 cases and 609,820 deaths recorded in 2023. Additionally, as reported by the British Heart Foundation, a UK-based charity, in September 2025, over 7.6 million people in the UK (comprising more than 4 million men and over 3.6 million women) are currently living with cardiovascular disease; forecasts suggest that this figure could increase by roughly 1 million by 2030 and about 2 million by 2040, influenced by an aging populace and better survival statistics. Consequently, the rising prevalence of cancer and chronic disorders acts as a key impetus for the mRNA synthesis of raw materials.
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Segment Breakdown: Which Categories Lead On Revenue?
The messenger ribonucleic acid (mrna) synthesis raw materials market covered in this report is segmented –
1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
Subsegments:
1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents
2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides
3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA
4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Transformation Trends: What Innovations Are Driving Change?
Leading companies within the messenger ribonucleic acid (mRNA) synthesis raw materials market are increasingly focusing on forming strategic collaborations to bolster their technological capabilities, broaden their range of high-quality raw materials, and accelerate the development of advanced mRNA therapeutics. These strategic collaborations denote formal partnerships established between biotechnology firms, enzyme developers, and nucleic acid technology providers, with the goal of jointly creating sophisticated IVT enzymes, modified nucleotides, capping analogs, or other essential components that improve mRNA yield, purity, stability, and safety. For instance, in September 2024, TriLink Biotechnologies, a US-based biotechnology company, partnered with Alphazyme LLC, a US-based custom molecular biology enzyme company, to introduce the CleanScribe RNA Polymerase. This next-generation IVT enzyme significantly reduces double-stranded RNA formation by up to 85% during mRNA synthesis, thereby contributing to the creation of safer and more potent mRNA therapeutics.
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Leading Players And Competitive Positioning
Major companies operating in the messenger ribonucleic acid (mrna) synthesis raw materials market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group Ltd., Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Integrated DNA Technologies Inc., LGC Biosearch Technologies, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc., Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.
View The Full Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report:
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the mRNA synthesis raw materials market in 2025. The regions covered in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
